Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing
Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240